Head to head
Teladoc Health vs Veeva Systems
Side-by-side on the measures that matter, with a plain-English read. Full detail: TDOC · VEEV
TDOC
Teladoc Health
5.56-3.64%
1-year price shape — -34% over the period
Quant Rating D · 52/100
vs
VEEV
Veeva Systems
282.50-0.35%
1-year price shape — -8% over the period
Quant Rating D · 32/100
1-year performance, rebased to 100
Veeva Systems edges it on the scoreable measures. Veeva Systems has done best over the past year (-8%); Veeva Systems earns the most per share.
| TDOC | VEEV | |
|---|---|---|
| Snapshot | ||
| Sector | -- | Health Information Services |
| Last price | 5.56 | 282.50 |
| Change today | -3.64% | -0.35% |
| 1-year return | -33.6% | -7.7% |
| Market cap | $1.01B | $45.74B |
| 52-week range | 4.40 – 9.89 | 148.05 – 302.17 |
| Valuation | ||
| P/E (TTM) | -5.62 | 46.31 |
| P/E percentile, own 5-yr range | 37th | 16th |
| P/B | 0.77 | 6.15 |
| Dividend yield | 0.00% | 0.00% |
| Profitability & growth | ||
| EPS (TTM) | -1.14 | 5.44 |
| Net profit (TTM) | $-207.12M | $880.78M |
| Revenue (TTM) | $2.49B | $3.46B |
| Revenue growth (YoY) | -4.0% | +17.6% |
| Gross margin | 69.0% | 75.0% |
| Operating margin | -5.9% | 29.9% |
| Net margin | -7.1% | 29.3% |
| Free cash flow (TTM) | $118.13M | $1.67B |
| Ownership & sentiment | ||
| Institutional ownership | 84.7% | 91.0% |
| Insider activity (12mo) | 17 buy / 33 sell | 29 buy / 18 sell |
| Short interest (% of float) | 15.2% | 3.1% |
| Analyst consensus | 40% buy / 60% hold (10) | 73% buy / 23% hold / 5% sell (22) |
| Analyst price target | $9 (+56%) | $295 (+4%) |
| StockVane view | ||
| StockVane Quant Rating | D (52) | D (32) |
| Company | ||
| Employees | 5,600 | 7,928 |
| Founded | 2002 | 2007 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.